Yaqiong Zhang
Taizhou, 318000, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications
7-Dehydrocholesterol-mediated ferroptosis is governed by glucose availability in pancreatic ductal adenocarcinoma.
Journal: Acta biochimica et biophysica Sinica
Published: August 12, 2026
Dynamic alterations of site-specific N-glycoform and plasma proteasome signatures stratify chemotherapy benefit in pancreatic ductal adenocarcinoma.
Journal: Molecular & cellular proteomics : MCP
Published: April 03, 2026
Disease classification via interpretable machine learning based on multi-center routine coagulation test.
Journal: Frontiers in molecular biosciences
Published: January 15, 2026
Development of a four-gene prognostic signature for hepatocellular carcinoma using TCGA and GEO datasets.
Journal: Discover oncology
Published: October 18, 2025
Hepatocyte BPGM Induces RET Lactylation and Macrophage Reprogramming to Promote Tumorigenesis in Hepatocellular Carcinoma.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: September 16, 2025
Matrine targets β-catenin and blocks the formation of β-catenin/TCF7L2 complex to promote ferroptosis and inhibit metastasis in triple-negative breast cancer.
Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology
Published: March 17, 2025
Network pharmacology, molecular docking and biological verification to explore the potential anti-prostate cancer mechanisms of Tripterygium wilfordii Hook. F.
Journal: Journal of ethnopharmacology
Published: June 05, 2024
Combination of Ablation and Immunotherapy for Hepatocellular Carcinoma: Where We Are and Where to Go.
Journal: Frontiers in immunology
Published: October 11, 2021
Anti-TLR4 IgG2 Prevents Acetaminophen-induced Acute Liver Injury through the Toll-like Receptor 4/MAPKs Signaling Pathway in Mice.
Journal: Current molecular medicine
Published: August 06, 2021
MicroRNA-1246 suppresses the metastasis of breast cancer cells by targeting the DYRK1A/PGRN axis to prevent the epithelial-mesenchymal transition.
Journal: Molecular biology reports
Published: July 30, 2021
MicroRNA-200c Inhibits the Metastasis of Triple-Negative Breast Cancer by Targeting ZEB2, an Epithelial-Mesenchymal Transition Regulator.
Journal: Annals of clinical and laboratory science
Published: August 23, 2020
Last Updated: 09/26/2026